Retraction: Behr TM, Griesinger F, Riggert J, et al. High‐dose myeloablative radioimmunotherapy of mantle cell non‐hodgkin lymphoma with the iodine‐131‐labeled chimeric anti‐CD20 antibody C2B8 and autologous stem cell support: results of a pilot study. Cancer. (2002) 94(4 Suppl):1363–72. [PDF]
openalex +1 more source
Radioimmunotherapy With WT1 Dendritic Cell Vaccine for End-Stage Lung Adenocarcinoma Markedly Shrinks Tumors. [PDF]
Nagai H, Karube R, Zhao F.
europepmc +1 more source
A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with <sup>89</sup>Zr/<sup>131</sup>I-Labeled Tinurilimab. [PDF]
Chen C+8 more
europepmc +1 more source
Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas [PDF]
John M. Pagel+8 more
openalex +1 more source
Assessing the Clinical Effectiveness of Radioimmunotherapy with Combined Radionuclide/Monoclonal Antibody Conjugates in Cancer Treatment: Insights from Randomised Clinical Trials. [PDF]
Chen Y+4 more
europepmc +1 more source
Multicenter Phase II Clinical Study of Iodine-131–Rituximab Radioimmunotherapy in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma [PDF]
Michael F. Leahy+3 more
openalex +1 more source
High-Dose [131I]Tositumomab (anti-CD20) Radioimmunotherapy and Autologous Hematopoietic Stem-Cell Transplantation for Adults ≥ 60 Years Old With Relapsed or Refractory B-Cell Lymphoma [PDF]
Ajay K. Gopal+9 more
openalex +1 more source